Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Long time listener. First time caller

Look, the ony thing that will get this stock moving in a meaningful way is if they can raise at least (by my back of the envelope calculations) at least 20 million dollars. Within 6 months one of 2 things will happen:

1. They raise 20 million or more, get on the NASDAQ, and start a canine trial. If that happens, we're off to the races.

2. They can't raise any money and go out of business.

I don't see much middle ground between the 2 options.

Share
New Message
Please login to post a reply